EichorEICHOR
Location: Changsha Synced from ClinicalTrials.gov · August 07, 2026

Clinical studies recruiting near Changsha

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Regional or Extend LymphAdenectomy During Resection of Intrahepatic Cholangiocarcinoma
NA · Hunan Provincial People's Hospital · Second Affiliated Hospital, Zhejiang University, School of M · NCT04078230Real-World Study on CDK4/6 Inhibitors Combined With Endocrine Therapy and Subsequent Treatment in HR+/HER2- MBC.
Phase N/A · Hunan Cancer Hospital · Hunan Cancer Hospital · NCT06033287Qishen Yiqi Dripping Pills in Treatment of Chronic Heart FailUre
Phase 3 · The First Affiliated Hospital of Hunan University of Chinese · Tasly Pharmaceutical Group Co., Ltd · NCT07687186A Prospective Multicenter Observational Real-world Study of Retained Products of Conception
Phase N/A · The Third Xiangya Hospital of Central South University · The Third Xiangya Hospital of Central South University · NCT07421895A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Phase 3 · Xiangya Hospital Central South University · Eli Lilly and Company · NCT07218380A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart
Phase 3 · CON-56008, Changsha, Hunan · Colorado Prevention Center · NCT06024746Carbon Nanoparticle-Loaded Iron in the Treatment of Advanced Solid Tumor
Phase 1/Phase 2 · Sichuan Enray Pharmaceutical Sciences Company · NCT07433283This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide W
Phase 3 · Hunan Cancer Hospital · Pfizer · NCT07028853Zhibitai Capsules for the Treatment of Primary Hyperlipidemia
Phase 2 · Xiangya Second Hospital of Central South University · Chengdu Diao Jiuhong Pharmaceutical Factory · NCT06822946High Definition Transcranial Direct Current Stimulation of Right Inferior Frontal Gyrus to Improve Social Impairments in
NA · The Second Xiangya Hospital of Central South University · Central South University · NCT06723522A Multicenter, Non-interventional, Descriptive Study to Assess Assay Concordance of HER2 IHC Testing in Chinese Pan-tumo
Phase N/A · Research Site · AstraZeneca · NCT07404202A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line
Phase 3 · Hunan Cancer Hospital ( Site 2020) · Merck Sharp & Dohme LLC · NCT06136559Study of HRS-8080 or SHR-A2009 Combined With Anti-tumor Therapy in Patients With Unresectable or Metastatic Breast Cance
Phase 1/Phase 2 · Hunan Cancer Hospital · Shandong Suncadia Medicine Co., Ltd. · NCT06222879Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease
Phase 2/Phase 3 · Local Institution - 0059 · Bristol-Myers Squibb · NCT07106762A Phase 2 Study of HB0017 in Psoriasis Patients
Phase 2 · Xiangya Hospital of Central South University · Huabo Biopharm Co., Ltd. · NCT06592274This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in
Phase 3 · Hunan Cancer Hospital · Pfizer · NCT06758401A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)
Phase 3 · Local Institution - 0184 · Bristol-Myers Squibb · NCT06929273Indomethacin vs Diclofenac for Preventing PEP
NA · The Third Xiangya Hospital of Central South University · Air Force Military Medical University, China · NCT07071441Evaluation of Rovadicitinib Compared to the Protocol Selected by Researchers in Third Line and Subsequent Studies of Mod
Phase 3 · The Second Xiangya Hospital of Central South University · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · NCT06682169Chemoradiotherapy in Esophageal or Esophagogastric Junction Cancer
Phase 3 · Hunan Cancer Hospital, the Affiliated Cancer Hospital of Xia · Cancer Institute and Hospital, Chinese Academy of Medical Sc · NCT04821778A Study to Learn About the Study Medicine (Called PF-07868489) in People With Pulmonary Arterial Hypertension Who Have P
Phase 2 · The Second Xiangya Hospital of Central South University · Pfizer · NCT07073820China Diabetes Type 1 Study (CD1S) by China Alliance for Type 1 Diabetes
Phase N/A · The Second Xiangya Hospital, Central South University · Second Xiangya Hospital of Central South University · NCT05498974A Study of BL-B01D1 in Patients With Locally Advanced or Metastatic Solid Tumor
Phase 1 · Hunan Cancer Hospital · Sichuan Baili Pharmaceutical Co., Ltd. · NCT05194982Rectal NSAIDs With/Without PD Stent for PEP Prevention
NA · The Third Xiangya Hospital of Central South University · Air Force Military Medical University, China · NCT07117318A Study of TQB2102 for Injection in the Treatment of HER2-positive Biliary Tract Cancer
Phase 1/Phase 2 · Hunan Provincial People's Hospital · Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharm · NCT06431490A Study of Single and Multiple Doses of HRS-6257 in Healthy Subjects
Phase 1 · Third Xiangya Hospital of Central South University · Shanghai Hengrui Pharmaceutical Co., Ltd. · NCT07301333A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carbop
Phase 3 · Hunan Cancer Hospital · Hoffmann-La Roche · NCT06793215A Phase I Clinical Study to Evaluate the PK Profile, Efficacy, Safety and Immunogenicity of HLX17 vs. Keytruda® in Multi
Phase 1 · The Third Xiangya Hospital of Central South University · Shanghai Henlius Biotech · NCT07160335The Impact of Transjugular Intrahepatic Portosystemic Shunt on Recompensation in Patients With Decompensated Liver Cirrh
Phase N/A · Second Xiangya Hospital, Central South University · Union Hospital, Tongji Medical College, Huazhong University · NCT07172035Efbemalenograstim Alfa Injection for Ovarian or Cervical Cancer Receiving Chemotherapy Regimen
Phase 2 · Xiangya Hospital, Central South University, · Shandong University · NCT06251947
Look up another city
Look up another condition
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.